Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Switching From PI to RALtegravir in HIV Stable Patients (SPIRAL)

This study has been completed.
Information provided by:
Hospital Clinic of Barcelona Identifier:
First received: September 10, 2007
Last updated: March 30, 2010
Last verified: May 2008